Liposomes: A targeted drug delivery system- A review
Abstract
Liposomes are a novel drug delivery system (NDDS), which are vesicular structures consisting of hydrated bilalyers which form spontaneously whenphospholipids are dispersed in water. They are simple microscopic vesicles in which an aqueous volume is entirely enclosed by a membrane composed of lipid bilayers. Novel drug delivery system aims to deliver the drug at a rate directed by the needs of the body during the period of treatment, and channel the active entity to the siteof action. It has been a study interest in the development of a NDDS. Liposomes are colloidal spheres of cholesterol non-toxic surfactants, sphingolipids, glycolipids, long chain fatty acids and even membrane proteins and drug molecules or it is also called vesicular system. It is differ in size, composition and charge. It is a drug carrier loaded with great variety of molecules such as small drug molecules, proteins, nucleotides and even plasmids. Few drugs are also formulated as liposomes to improve their therapeutic index. Consequently a number of vesicular drug delivery systems such as liposomes, niosomes, transfersomes, and pharmacosomes were developed. The focus of this review is to the various method of preparation, characterization of liposomes, advantages and applications etc.
Downloads
References
Bangham, A.D. Liposomes in Biological Systems, John Wiley and Sons: Chichester, 1980.
Chapman D. Liposomal technology. 1983;1:1-18.
Jayakrishnan, A.; Latha, M.S. Controlled and Novel Drug Delivery, B.S. Pub: New Delhi, 1997.
Sessa, G.; Weismann, G. Journal of Journal of Biological Chemistry, 1970, 245, 3295.
Gregoriadis, G.Methods in Enzymology, 1976, 44, 278.
Dunnick, J. K.; Rooke, J D.; Aragon, S.; Kriss, J. P. Cancer. Res., 1976, 36, 2385-2389.
Bangham A.D., Standish M.M. and Watlins J.C. (1965). J. Mol. Biol. 13: 238.
Bangham A.D., Hill M.W. and Miller N.G.A. (1974). In: Methods in Membrane Biology (Korn N.D., ed.) Plenum. N.Y., Vol.1, p.l.
Papahadjopoulos D. and Watkins J.C. (1978). BiochimicaetBiophysica,135: 639.
Gruner S.M., Leak R.P., Jan off S. and Ostro M.J. (1985). Biochem. 24: 2833
Kim S., Jacobs R.E. and White S.H. (1985). BiochimicaetBiophysicaActa, 812: 793.
Oezden M.Y. and Hasirci V.N. (1991). BiochimicaetBiophysicaActa. 1075: 102.
Hamilton R.L. and Guo L.S.S. (1984). In: Liposome Technology (Gregoriadis G. ed.) CRC Press, Florida, Vol.1, Chapter 4, p.37.
Lasic D.D., Kidric J. and Zagorc S. (1987). BiochimicaetBiophysicaActa. 896: 117.
Deamer D. and Bangham A.D. (1976). BiochimicaetBiophysicaActa. 443: 629.
Schieren H., Rudolph S., Findelstein M., Coleman P. and Weissmann G. (1978). BiochimicaetBiophysicaActa. 542: 137.
Batzri S. and Korn E.D. (1973). BiochimicaetBiophysica. 298: 1015.
Kagawa Y. and Racker E. (1974).Journal of Biological Chemistry. 246: 5477
Milsmann M.H.W., Schwendener R.A. and Wader H. (1978).BiochimicaetBiophysicaActa. 512: 147.
Alpes H., Allmann K., Plattner H., Reichert J., Rick R. and Schulz S. (1986).BiochimicaetBiophysicaActa. 862: 294.
Enoch H.G. and Strittmatter P. (1979).Proceedings of the National Academy of Sciences,USA. 76: 145
Gerritson W.J., Verkley A.J., Zwaal R.F.A. and van Deenan L.L.M. (1978). European Journal of Biochemistry,85: 255.
Philippot J.R., Mutafschicv S. and Liautard J.P. (1985).BiochimicaetBiophysicaActa. 821: 79.
Szoka F. Jr. and Papahadjopoulos D. (1978). Proceedings of the National Academy of Sciences, USA. 75: 4194.
Handa T., Takeuchi H., Phokubo Y. and Kawashima Y. (1987). Chemical& pharmaceutical bulletin. 35: 748.
Haga N. and Yogi K. (1989). Journal of Clinical Biochemistry and Nutrition. 7: 175.
Papahadjopoulos D. and Vail W.J. (1978).Annals of the New York Academy of Sciences. 308: 259.
Mayhew E., Lazo R., Vail WJ, King J. and Green A.M. (1984).BiochimicaetBiophysicaActa. 775: 169.
Riaz M. and Weiner N. (1995). Pakistan Journal of Pharmaceutical Sciences.
Jousma H., Talsma H., Spies F., Joosten J.G.H., Junginger H.E. and Crommelin D.J.A. (1987). International Journal of Pharmaceutics. 35: 263.
Riaz M. and Weiner N. (1994). Pakistan Journal of Pharmaceutical Sciences. 7: 61.
Lasic D.D., Belie A. and Valentincic T. (1988) J. Ant. Client. Soc. 110: 970
Liautard J.P. and Phillippot J.R. (1993).Journal of Liposome Research. 63.
Pick U. (1981). Arch. Biochem. Biophys. 212: 186.
Ohsawa T., Miura H. and Harada K. (1985). Chemical& pharmaceutical bulletin. 33: 3945.
Liu L. and Yonetaini T. (1994).Journal of Microencapsulation.11: 409.
Oku N., Scheerer J.F. and McDonald R.C. (1982).BiochimicaetBiophysicaActa. 692: 384
Oku N. and MacDonald R.C. (1983).BiochimicaetBiophysicaActa. 734: 54.
Kim S., Turker M.S., Chi E.Y., Scla S. and Martin G.M. (1983).BiochimicaetBiophysicaActa. 728: 339.
Cullis R.P., Hope M.J., Bally M.B., Madden T.D. and Jan off AS. (1987). In: Liposomes from Biophysics to Therapeutics (Ostro M. J., Ed.) Marcel Dekker, N.Y., Chapter 2, p.39.39
Op den Kamp J.A.F. (1979). Ann. Rev. Biochem. 48: 47.
Cestaro B., Pistolesi E., Hershkowitz N. and Galt S. (1982).BiochimicaetBiophysicaActa. 685:13.
Pagano R.E., Martin O.C., Schroit A.J. and Struck D.K. (1981). Biochemistry. 20: 4920.
Low M.G. and Zilversmit D.D. (1980).BiochimicaetBiophysicaActa. 596: 223.
Christopher Kirby, Jacqui Clarke, Gregory Gregoriadis. Effect of the Cholesterol Content of Small Unilamellar. Liposomes on their Stability in vivo and in vitro. Biochem. J., 186, 1980, 591-598.
Omar Moh’dAtrouse. The Effect of liposome Composition and Temperature on the Stability of Liposomes and the Interaction of liposomes with Human Neutrophils. Pakisthan Journal of Biological Sciences, 5(9), 2002, 948-951.
ArkadiuszKozubek, Jerzy Gubernator, EwaPrzeworska, Maria Stasiuk Liposomal drug delivery, a novel approach: PLARosomes. ActaBiochimicaPolonica, 47(3), 2000, 639–649.
Popescu D, Popescu AG, Amuzescu B Pulsatory. Liposomes – A Possible Biotechnological Device for Controlled Drug Delivery. I. The Liposome Swelling. Romanian J. Biophys., 20(1), 2010, 37–46.
TiwariSandip B, Udupa N, Rao BSS, Uma Devi P. Thermosensitive Liposomes AndLocalised Hyperthermia – An Effective Bimodality Approach For Tumour Management. Indian Journal of Pharmacology, 32, 2000, 214-220.
Rakesh P Patel, Hardik Patel, Ashok H Baria. Formulation and Evaluation of Liposomes of Ketoconazole. International Journal of Drug Delivery Technology, 2009, 1(1), 16-23.
Rania M Hathout, Samar Mansour, Nahed D Mortada, Ahmed S Guinedi. Liposomes as an Ocular Delivery System for Acetazolamide. In Vitro and In Vivo Studies. AAPS PharmSciTech.,2007, 8(1), E1-12
Barbara Cybulska, Karolina Kupczyk, Joanna Szlinder-Richert, Edward Borowski. Comparative in vitro studies on liposomal formulations of amphotericin B and its derivative, N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME). ActaBiochimicaPolonica, 2002, 49(1), 67-75.
SoleimanMohammadi-Samani, HashemMontaseri, MinooJamshidnejad. Preparation and Evaluation of Cyproterone Acetate Liposome for Topical Drug Delivery. Iranian Journal of Pharmaceutical Sciences Autumn, 2009, 5(4), 199-204.
Paul G Tardi, Nancy L Boman, Pieter R Cullis. Liposomal Doxorubicin. J. drug targeting.,1996, 4(3), 129-140.
Shuqin Xia, ShiyingXu. Ferrous sulfate liposomes: preparation, stability and application in fluid milk. Food Research International, 2005, 38, 289–296.
Abeer AW Elzainy et al; Hydroxyzine From Topical Phospholipid Liposomal Formulations: Evaluation of Peripheral Antihistaminic Activity and Systemic Absorption in a Rabbit Model. AAPS PharmSci.,2003, 5(4), 41-48.
Yan-Li Hao et al; In Vitro and In Vivo Studies of Different Liposomes Containing Topotecan. Arch Pharm Res.,2005, 28(5), 626-635.
Tao Yang et al; Enhanced solubility and stability of PEGylated liposomal paclitaxel: In vitro and in vivo evaluation. International Journal of Pharmaceutics,2007, 338, 317–326.
ParveenGoyal et al; Liposomal drug delivery systems € ClinicaApplications,Acta Pharm, 2005, 55(3): 1€25.
Copyright (c) 2015 Acta Medica Scientia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
A) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
B) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
C) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
